Vitamin D deficiency: gender characteristics

• Elena I. Kondratyeva
• Elena V. Loshkova
• Irina N. Zakharova
• Tatiyana V. Saprina
• Yulia F. Shubina
• Victoria S. Nikonova
• Yulia L. Mel'yanovskaya
• Aisa E. Zodbinova
• Niso D. Odinaeva

Abstract

Studies assessing vitamin D status are relevant both in the world and in the Russian Federation to determine the frequency of 25(OH)D deficiency, the severity of vitamin D metabolism disorders and focus populations with the greatest problems in vitamin D supply. We have shown that men are extremely rare determine the status 25(OH)D. It was found that 83% of men have severe vitamin D deficiency with a median of 19.40 ng/ml and 82.8% of women, with a median of 19.80 ng/ml. The most vulnerable age groups with low vitamin D supply in men are early childhood and young age from 19 to 22 years. In the female population, the lowest values of 25(OH)D (18.84 ng/ml) are observed in old age.

Keywords:vitamin D deficiency, children, adults, men, women

REFERENCES

1. National program «Vitamin D deficiency in children and adolescents of the Russian Federation: modern approaches to correction». In: Union of Pediatricians of Russia et al. Moscow: Pediatr, 2018: 96 p. (in Russian)

2. Pigarova E.A., Rozhinskaya L. Ya., Belaya Zh.E., et al. Clinical guidelines of the Russian Association of Endocrinologists for the diagnosis, treatment and prevention of vitamin D deficiency in adults. Problemy en-dokrinologii [Problems of Endocrinology]. 2016; 62 (4): 60-84. (in Russian)

3. Petrushkina A.A., Pigarova E.A., Rozhinskaya L. Ya. The prevalence of vitamin D deficiency in Russian Federation. Osteoporoz i osteopatii [Osteoporosis and Osteopathy]. 2018; 21 (3): 15-20. DOI: https://doi.org/10.14341/osteo10038 (in Russian)

4. Amrein K., Scherkl M., Hoffmann M., et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 74: 1498-513. DOI: https://doi.org/10.1038/s41430-020-0558-y

5. Rinonapoli G., Ruggiero C., Meccariello L., Bisaccia M., Ceccarini P., Car-affa A. Osteoporosis in men: a review of an underestimated bone condition. Int J Mol Sci. 2021; 22 (4): 2105. DOI: https://doi.org/10.3390/ijms22042105 PMID: 33672656; PMCID: PMC 7924179.

6. Crowe F.L., Jolly K., MacArthur C., Manaseki-Holland S., Gittoes N., Hewison M., et al. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005-2015. BMJ Open. 2019; 9 (6): e028355.

7. Martucci G., Tuzzolino F., Arcadipane A., Pieber T.R., Schnedl C., Urbanic Purkart T., et al. The effect of high-dose cholecalciferolon bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial. Intensive Care Med. 2017; 43: 1732-4. DOI: https://doi.org/10.1007/s00134-017-4846-5

8. Cashman K.D., Dowling K.G., Skrabakova Z., Gonzalez-Gross M., Valtuena J., De Henauw S., et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016; 103: 1033-44. DOI: https://doi.org/10.3945/ajcn.115.120873

9. Grant W.B., Boucher B.J. Why secondary analyses in vitamin d clinical trials are important and how to improve vitamin d clinical trial outcome analyses - a comment on «Extra-Skeletal Effects of Vitamin D, Nutrients. 2019, 11, 1460». Nutrients. 2019; 11: 2182.

10. Manson J.E., Cook N.R., Lee I.M., Christen W., Bassuk S.S., Mora S., et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2018; 380: 33-44. DOI: https://doi.org/10.1056/NE-JMoa1809944

11. Pittas A.G., Dawson-Hughes B., Sheehan P., Ware J.H., Knowler W.C., Aroda V.R., et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019; 381: 520-30. DOI: https://doi.org/10.1056/NE-JMoa1900906

12. Zhang Y., Fang F., Tang J., Jia L., Feng Y., Xu P., et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019; 366: I4673. DOI: https://doi.org/10.1136/bmj.14673

13. Amrein K., Martucci G., McNally J.D. When not to use meta-analysis: analysing the meta-analyses on vitamin D in critical care. Clin Nutr. 2017;36: 1729-30. DOI: https://doi.org/10.1016/j.clnu.2017.08.009

14. Babenko A. Yu., Laevskaya M. Yu. Osteoporosis. Gender characteristics of prevention and treatment. RMZh [Russian Medical Journal]. 2017; (22): 1646-50. (in Russian)

15. Lesnyak O.M. Topical issues of diagnosis and treatment of osteoporosis in men in outpatient practice. Rossiyskiy semeyniy vrach [Russian Family Doctor]. 2017; 21 (1) 39-44. (in Russian)

16. Curtis E.M., et al. Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone. 2016; 87: 19-26.

17. Willson T., Nelson S.D., Newbold J., Nelson R.E., LaFleur J. The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol. 2015; 7: 65-76. DOI: https://doi.org/10.2147/CLERS 40966 PMID: 25657593; PMCID: PMC 4295898.

18. Bouillon R., Carmeliet G., Lieben L., Watanabe M., Perino A., Auwerx J., et al. Vitamin D and energy homeostasis: of mice and men. Nat Rev Endocrinol. 2014; 10: 79-87. DOI: https://doi.org/10.1038/nrendo.2013.226

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)